As per the agreement, Lonza is expected to support process scale-up, technology transfer, validation, and commercial manufacturing at one of its facilities in the US. Lonza was optimised
Eisai Inc has received exclusive rights to market and distribute Lorcaserin in the US from Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals. Eisai said that
Cubicin is approved in the US and many other markets as therapy for Staphylococcus aureus bloodstream infections (bacteremia), including right-sided endocarditis caused by methicillin-resistant S aureus (MRSA), and
As per the terms of the collaboration, PPD and LBERI are expected to refer to one another business opportunities for laboratory, preclinical and clinical development services they do
Meridian Biosciencesaidthat the new illumigene C difficile molecular diagnostic system also provides high levels of sensitivity for diagnosing the serious, infectious disease. Its simple workflow requires minimal hands-on
Emergent BioSolutions said that the contract is a two-year base period of performance valued at $54.6m and three option years that, if exercised by BARDA, would increase the
Amira’s newly granted claims cover new inhibitors of the FLAP protein. The patent also discloses uses of FLAP inhibitors for the treatment of inflammatory diseases such as asthma,
Pixantrone is a new aza-anthracenedione. Similar to anthracyclines, Pixantrone inhibits Topo-isomerase II but unlike anthracyclines, rather than intercalation with DNA, Pixantrone alkylates DNA, forming stable DNA adducts, with
As per the terms of the agreement, that was signed in July 2007, Silence and AstraZeneca are jointly collaborating in the identification and optimisation of five new siRNA
NEB said that all the necessary enzymes and buffers for fast fragment library preparation are provided by these new products. Additionally, the Master Mix Set further streamlines the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.